Beximco Pharmaceuticals will sell the generic version Gilead Sciences' antiviral drug.
The Dhaka-based Beximco, which counts Norges Bank as one of its investors, will sell remdesivir for about 6,000 taka ($71) a vial to private clinics but will give it free to state-run hospitals treating Covid-19 patients, Rabbur Reza, chief operating officer at the company, said in an interview.
Drug maker AstraZeneca
said on Thursday it had secured its first agreements for 400 million doses of a Covid-19 vaccine it is testing, bolstered by an investment from the US vaccine agency. The Anglo-Swedish firm had received more than $1 billion from the US Biomedical Advanced Research and Development Authority for the development, production and delivery of the vaccine. AP/PTI